Back

The added role of myocardial work in anderson-fabry or amyloidosis cardiomyopathy

22 May 2023 (12:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Myocardial disease - hypertrophic cardiomyopathy 1 Hypertrophic Cardiomyopathy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Fabrizio De Gaetano

Cannizzaro Hospital, Catania (Italy)

7 More presentations in this session

Presentation thumbnail
Rarefaction of myocardial lymphatic vessels in patients with cardiac amyloidosis
Doctor M. Emdin (Pisa, IT)
Abstract Slides
Presentation thumbnail
Do we need lower cut-offs of left ventricular wall thickness to suspect cardiac amyloidosis in women?
Doctor A. Aimo (Pisa, IT)
Abstract Slides
Presentation thumbnail
External validation and extension of the HCM-AF score for the prediction of atrial fibrillation in hypertrophic cardiomyopathy patients.
Doctor G. Cediel Calderon (Tarragona, ES)
Abstract Slides
Presentation thumbnail
Effectiveness of alcohol septal ablation for hypertrophic obstructive cardiomyopathy in patients with late gadolinium enhancement on cardiac magnetic resonance
Doctor E. Polakova (Prague, CZ)
Abstract Slides
Presentation thumbnail
Clinical burden of obstructive hypertrophic cardiomyopathy: insights from a nationwide study in France
Professor P. Charron (Paris, FR)
Abstract Slides

Access the full session

Session thumbnail
Myocardial disease - hypertrophic cardiomyopathy 1

The Event

Event poster

Heart Failure 2023

22 May 2023 12:00 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources